Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Panou

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Hormones (Athens, Greece)|October 14, 2025
What ultimately underlies vitamin B12 and folate deficiency in subjects treated with biguanides?Theodoros Panou, Byron Asimakopoulos
Frontiers in Endocrinology|April 16, 2026
New pharmacological agents and emerging therapeutic targets for painful diabetic neuropathyTheodoros Panou, Nikolaos Papanas, Peter Kempler
Biomedicines|May 27, 2026
The Role of Dipeptidyl Peptidase Inhibitors in Pulmonary DiseasesTheodoros Panou, Paschalis Steiropoulos, Fotios Drakopanagiotakis
Healthcare (Basel, Switzerland)|February 13, 2026
The Natural History of Obstructive Sleep Apnea: A Scoping ReviewAlexandros Kalkanis, Theodoros Panou, Kostas Archontogeorgis, et al.
Metabolism Open|November 19, 2024
The role of novel inflammation-associated biomarkers in diabetic peripheral neuropathyTheodoros Panou, Evanthia Gouveri, Dimitrios Papazoglou, et al.
Expert Review of Clinical Pharmacology|September 24, 2024
Amylin analogs for the treatment of obesity without diabetes: present and futureTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Expert Review of Clinical Pharmacology|November 23, 2025
Orforglipron in type 2 diabetes mellitus and obesity: an overviewTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Advances in Therapy|April 16, 2026
Glucagon-Like Peptide-1 Receptor Agonists: Their Therapeutic Potential in Cystic FibrosisTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Expert Review of Clinical Pharmacology|March 5, 2026
Retatrutide in type 2 diabetes mellitus and obesity: an overviewTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Expert Review of Clinical Pharmacology|June 4, 2026
Tirzepatide in type 1 diabetes: beyond mere weight lossTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Hormones (Athens, Greece)|October 14, 2025
What ultimately underlies vitamin B12 and folate deficiency in subjects treated with biguanides?Theodoros Panou, Byron Asimakopoulos
Frontiers in Endocrinology|April 16, 2026
New pharmacological agents and emerging therapeutic targets for painful diabetic neuropathyTheodoros Panou, Nikolaos Papanas, Peter Kempler
Biomedicines|May 27, 2026
The Role of Dipeptidyl Peptidase Inhibitors in Pulmonary DiseasesTheodoros Panou, Paschalis Steiropoulos, Fotios Drakopanagiotakis
Healthcare (Basel, Switzerland)|February 13, 2026
The Natural History of Obstructive Sleep Apnea: A Scoping ReviewAlexandros Kalkanis, Theodoros Panou, Kostas Archontogeorgis, et al.
Metabolism Open|November 19, 2024
The role of novel inflammation-associated biomarkers in diabetic peripheral neuropathyTheodoros Panou, Evanthia Gouveri, Dimitrios Papazoglou, et al.
Expert Review of Clinical Pharmacology|September 24, 2024
Amylin analogs for the treatment of obesity without diabetes: present and futureTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Expert Review of Clinical Pharmacology|November 23, 2025
Orforglipron in type 2 diabetes mellitus and obesity: an overviewTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Advances in Therapy|April 16, 2026
Glucagon-Like Peptide-1 Receptor Agonists: Their Therapeutic Potential in Cystic FibrosisTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Expert Review of Clinical Pharmacology|March 5, 2026
Retatrutide in type 2 diabetes mellitus and obesity: an overviewTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Expert Review of Clinical Pharmacology|June 4, 2026
Tirzepatide in type 1 diabetes: beyond mere weight lossTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Pageof 3